Log in

Alexion Pharmaceuticals SEC Filings & 10K Form (NASDAQ:ALXN)

$103.14
+0.60 (+0.59 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$101.52
Now: $103.14
$103.21
50-Day Range
$99.39
MA: $106.06
$113.92
52-Week Range
$94.59
Now: $103.14
$141.86
Volume1.73 million shs
Average Volume2.01 million shs
Market Capitalization$22.84 billion
P/E Ratio9.61
Dividend YieldN/A
Beta1.68

SEC Filings

Alexion Pharmaceuticals (NASDAQ:ALXN) SEC Filings

DateFilerForm TypeView
02/13/2020
9:36 AM
Alexion Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/12/2020
10:01 AM
Alexion Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/10/2020
4:00 PM
Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
3:58 PM
Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
3:57 PM
Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
3:56 PM
Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
5:30 AM
Alexion Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/30/2020
5:34 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2020
8:47 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
5:18 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
9:25 AM
Alexion Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
12/04/2019
5:52 PM
Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
5:38 PM
Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
Form 3/A
12/04/2019
5:36 PM
Alexion Pharmaceuticals (Issuer)
SARIN ARADHANA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
3:37 PM
Alexion Pharmaceuticals (Issuer)
Carino Tanisha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
3:44 PM
Alexion Pharmaceuticals (Issuer)
Carino Tanisha (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2019
6:56 AM
Alexion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2019
6:13 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2019
4:27 PM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2019
7:53 AM
Alexion Pharmaceuticals (Filer)
Form DEFA14A
10/16/2019
7:50 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2019
3:12 PM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2019
7:00 AM
Alexion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2019
5:46 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2019
4:01 PM
Alexion Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
3:41 PM
Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:45 PM
Alexion Pharmaceuticals (Issuer)
SARIN ARADHANA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
5:39 PM
Alexion Pharmaceuticals (Issuer)
ORLOFF JOHN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
5:38 PM
Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
5:37 PM
Alexion Pharmaceuticals (Issuer)
LAW ANNE-MARIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
5:35 PM
Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2019
4:16 PM
667, L.P. (Reporting)
Alexion Pharmaceuticals (Issuer)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
3:58 PM
667, L.P. (Reporting)
Alexion Pharmaceuticals (Issuer)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
3:42 PM
Alexion Pharmaceuticals (Issuer)
Brennan David R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
3:37 PM
Alexion Pharmaceuticals (Issuer)
Nader Francois (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
3:36 PM
Alexion Pharmaceuticals (Issuer)
Mollen John T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
3:34 PM
Alexion Pharmaceuticals (Issuer)
Dunsire Deborah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
3:27 PM
Alexion Pharmaceuticals (Issuer)
Reinsdorf Judith A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
3:03 PM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2019
7:51 AM
Alexion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2019
5:54 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2019
7:36 AM
Alexion Pharmaceuticals (Filer)
Form DEFA14A
03/26/2019
7:32 AM
Alexion Pharmaceuticals (Filer)
Form DEF 14A
03/05/2019
7:24 PM
Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
7:23 PM
Alexion Pharmaceuticals (Issuer)
SARIN ARADHANA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
7:21 PM
Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
7:19 PM
Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
7:18 PM
Alexion Pharmaceuticals (Issuer)
ORLOFF JOHN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
7:16 PM
Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
7:14 PM
Alexion Pharmaceuticals (Issuer)
Chiniara Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
7:13 PM
Alexion Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
7:12 PM
Alexion Pharmaceuticals (Issuer)
LAW ANNE-MARIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
4:45 PM
Alexion Pharmaceuticals (Issuer)
SARIN ARADHANA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
4:43 PM
Alexion Pharmaceuticals (Issuer)
Chiniara Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
4:42 PM
Alexion Pharmaceuticals (Issuer)
ORLOFF JOHN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
4:40 PM
Alexion Pharmaceuticals (Issuer)
LAW ANNE-MARIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
4:39 PM
Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
4:37 PM
Alexion Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
4:36 PM
Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
4:35 PM
Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
4:33 PM
Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
3:30 PM
Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
8:10 PM
Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2019
6:29 PM
Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2019
6:27 PM
Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/19/2019
5:31 PM
Alexion Pharmaceuticals (Issuer)
SARIN ARADHANA (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/14/2019
12:48 PM
Alexion Pharmaceuticals (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
02/12/2019
11:10 AM
Alexion Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
02/11/2019
5:39 PM
Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2019
5:21 PM
Alexion Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2019
5:20 PM
Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2019
5:18 PM
Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2019
9:30 AM
Alexion Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/06/2019
8:03 AM
Alexion Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/04/2019
9:09 AM
Alexion Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
02/04/2019
5:37 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2019
5:07 PM
Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
10:29 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2018
11:00 AM
Alexion Pharmaceuticals (Filer)
Form CT ORDER
11/30/2018
5:15 PM
Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2018
5:10 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
9:38 AM
Alexion Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
10/24/2018
3:27 PM
Alexion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2018
5:46 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2018
4:26 PM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2018
4:20 PM
Alexion Pharmaceuticals (Filer)
Form S-3ASR
07/26/2018
3:40 PM
Alexion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2018
5:55 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2018
4:23 PM
Alexion Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2018
5:03 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2018
3:52 PM
Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
3:51 PM
Alexion Pharmaceuticals (Issuer)
LAW ANNE-MARIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
3:51 PM
Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
3:51 PM
Alexion Pharmaceuticals (Issuer)
ORLOFF JOHN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
9:19 AM
Alexion Pharmaceuticals (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
05/11/2018
3:44 PM
667, L.P. (Reporting)
Alexion Pharmaceuticals (Issuer)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2018
3:16 PM
Alexion Pharmaceuticals (Issuer)
Brennan David R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2018
3:15 PM
Alexion Pharmaceuticals (Issuer)
Reinsdorf Judith A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2018
3:14 PM
Alexion Pharmaceuticals (Issuer)
COUGHLIN CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2018
3:13 PM
Alexion Pharmaceuticals (Issuer)
Dunsire Deborah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel